Company Filing History:
Years Active: 2001
Title: The Innovations of Jean-Charles Fruchart
Introduction
Jean-Charles Fruchart is a notable inventor based in Lambersart, France. He has made significant contributions to the field of biotechnology, particularly in the area of apolipoproteins. His work has implications for therapeutic applications, especially in gene therapy.
Latest Patents
Fruchart holds a patent for "Variants of apolipoprotein A-I." This invention relates to variants of the human apolipoprotein A-I that include a cysteine at position 151. The patent also covers the corresponding nucleic acids and vectors containing them. Additionally, it discusses pharmaceutical compositions that incorporate these elements and their utilization in gene therapy.
Career Highlights
Jean-Charles Fruchart is associated with Aventis Pharmaceuticals Products Inc., where he has been able to apply his expertise in biotechnology. His work has contributed to advancements in medical treatments and therapeutic strategies.
Collaborations
Throughout his career, Fruchart has collaborated with notable colleagues such as Patrick Benoit and Eric Bruckert. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Jean-Charles Fruchart's contributions to biotechnology, particularly through his patent on apolipoprotein A-I variants, highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and pharmaceutical applications.